Group One Trading’s China Biologic Products Holdings, Inc. CBPO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-285
| Closed | -$34K | – | 8904 |
|
|
2021
Q1 | $34K | Hold |
285
| – | – | ﹤0.01% | 6480 |
|
|
2020
Q4 | $34K | Buy |
285
+118
| +71% | +$13.7K | ﹤0.01% | 5239 |
|
|
2020
Q3 | $19K | Buy |
+167
| New | +$17.9K | ﹤0.01% | 5169 |
|
|
2020
Q2 | – | Sell |
-22
| Closed | -$2.35K | – | 6536 |
|
|
2020
Q1 | $2K | Buy |
+22
| New | +$2.53K | ﹤0.01% | 5042 |
|
|
2019
Q4 | – | Sell |
-69,986
| Closed | -$8.11M | – | 5994 |
|
|
2019
Q3 | $8.01M | Buy |
69,986
+55,908
| +397% | +$5.56M | 0.06% | 365 |
|
|
2019
Q2 | $1.34M | Buy |
14,078
+12,585
| +843% | +$1.19M | 0.01% | 1379 |
|
|
2019
Q1 | $136K | Sell |
1,493
-9,315
| -86% | -$762K | ﹤0.01% | 2967 |
|
|
2018
Q4 | $820K | Buy |
+10,808
| New | +$795K | 0.01% | 1651 |
|
|
2016
Q4 | – | Sell |
-4,714
| Closed | -$551K | – | 5145 |
|
|
2016
Q3 | $587K | Sell |
4,714
-10,671
| -69% | -$1.26M | 0.01% | 1701 |
|
|
2016
Q2 | $1.64M | Buy |
15,385
+12,600
| +452% | +$1.46M | 0.02% | 928 |
|
|
2016
Q1 | $319K | Buy |
2,785
+200
| +8% | +$23.5K | ﹤0.01% | 2009 |
|
|
2015
Q4 | $368K | Sell |
2,585
-1,331
| -34% | -$154K | ﹤0.01% | 2055 |
|
|
2015
Q3 | $352K | Buy |
+3,916
| New | +$413K | ﹤0.01% | 2058 |
|
Group One Trading's CBPO Position: Q2 2021 in Review
Group One Trading sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2021, closing a stake of 285 shares — an estimated $34K sold.
Group One Trading first reported a position in CBPO in Q3 2015 and held it in 13 quarters. The position peaked at $8.01M in Q3 2019. 0 funds tracked by Wall St. Rank hold CBPO as of Q2 2021.
- Group One Trading reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2021 after selling out during the quarter.
- Group One Trading sold 285 China Biologic Products Holdings, Inc. shares in Q2 2021, an estimated $34K.
- Group One Trading first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 13 quarters.
- Group One Trading's China Biologic Products Holdings, Inc. position peaked at $8.01M in Q3 2019.
- 0 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2021.
Based on Group One Trading's 13F filing for Q2 2021, filed 10 Aug 2021.